flow trial semaglutide kidney outcomes nejm 2024 hazard ratio significant 24% reduction in disease progression and death related to kidney and cardiovascular causes in those treated with compared to a placebo Kidney and Survival Outcomes with

Int J Clin Exp Med 8(8):1200912017 Caiado F, Manz MG (2025) Gut microbiota fuels clonal hematopoiesis

This is normal and to be expected

Regarding floaters specifically, ophthalmologists have consistently emphasized these are not directly Ozempic-related but rather result from normal vitreous detachment that occurs with age, particularly in people over 50

Now he ended up taking oral BPC-157, GHK-Cu in CJC every single day

At the same time, patients are still being treated with sulfonylureas, which can actually be harmful to our patients

Wegovy is given in higher doses compared to Ozempic for the purpose of chronic weight management